The effect of dextran on microvascular thrombosis in an experimental rabbit model.
Although low molecular weight dextran is commonly utilized in clinical microsurgery, few experimental data are available documenting its efficacy. Bilateral 2-mm arterial inversion grafts were constructed in the femoral arteries of New Zealand White rabbits. The experimental group (n = 40 grafts) received a 5-day constant infusion of intravenous dextran 40 at 2.1 ml/hour, and the control group (n = 50 grafts) received no infusion. Whereas 85 percent (34/40) of the dextran grafts were patent at 1 week, only 48 percent (24/50) of the control grafts were patent (p = 0.0003). Scanning electron micrographs revealed a decrease in both platelet and fibrin deposition in the patent dextran arterial inversion grafts versus the patent control specimens. As a marked diminution in microvascular thrombosis was demonstrated at a clinically relevant dose, the continued use of intravenous dextran 40 in clinical microsurgery is supported by this study.
Rothkopf
D M
DM
Department of Surgery, University of Massachusetts Medical Center, Worcester.
Chu
B
B
Bern
S
S
May
J W
JW
D000818:Animals; D001792:Blood Platelets / Q000000981:diagnostic imaging; D003911:Dextrans / Q000008:administration & dosage / Q000494:pharmacology*; D005263:Femoral Artery / Q000601:surgery; D007262:Infusions, Intravenous; D008833:Microcirculation; D008855:Microscopy, Electron, Scanning; D008866:Microsurgery; D011183:Postoperative Complications / Q000517:prevention & control*; D011817:Rabbits; D013927:Thrombosis / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D014463:Ultrasonography; D014654:Vascular Patency; D014656:Vascular Surgical Procedures
D003911:Dextrans